Patrick R. Harrington, Ph.D. - Publications

Affiliations: 
2003 University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Microbiology Biology

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Chan-Tack K, Harrington P, Bensman T, Choi SY, Donaldson E, O'Rear J, McMillan D, Myers L, Seaton M, Ghantous H, Cao Y, Valappil T, Birnkrant D, Struble K. Benefit-risk assessment for brincidofovir for the treatment of smallpox: U.S. Food and Drug Administration's Evaluation. Antiviral Research. 105182. PMID 34582915 DOI: 10.1016/j.antiviral.2021.105182  0.54
2017 Harrington PR, Komatsu TE, Deming DJ, Donaldson EF, O'Rear JJ, Naeger LK. Impact of Hepatitis C Virus Polymorphisms on Direct-Acting Antiviral Treatment Efficacy: Regulatory Analyses and Perspectives. Hepatology (Baltimore, Md.). PMID 29194682 DOI: 10.1002/Hep.29693  0.68
2017 Boyd SD, Tracy L, Komatsu TE, Harrington PR, Viswanathan P, Murray J, Sherwat A. US FDA Perspective on Elbasvir/Grazoprevir Treatment for Patients with Chronic Hepatitis C Virus Genotype 1 or 4 Infection. Clinical Drug Investigation. PMID 28102520 DOI: 10.1007/S40261-017-0492-5  0.359
2016 Komatsu TE, Boyd S, Sherwat A, Tracy L, Naeger LK, O'Rear JJ, Harrington PR. Regulatory Analysis of Effects of Hepatitis C Virus NS5A Polymorphisms on Efficacy of Elbasvir and Grazoprevir. Gastroenterology. PMID 27773808 DOI: 10.1053/J.Gastro.2016.10.017  0.378
2016 Naeger LK, Harrington P, Komatsu T, Deming D. Effect of dolutegravir functional monotherapy on HIV-1 virological response in integrase strand transfer inhibitor resistant patients. Antiviral Therapy. 21: 481-488. PMID 26866979 DOI: 10.3851/IMP3033  0.623
2015 Lontok E, Harrington P, Howe A, Kieffer T, Lennerstrand J, Lenz O, McPhee F, Mo H, Parkin N, Pilot-Matias T, Miller V. Hepatitis C Virus Drug Resistance-associated Substitutions: State of the Art Summary. Hepatology (Baltimore, Md.). PMID 26095927 DOI: 10.1002/Hep.27934  0.34
2015 Harrington PR, Fleischer R, Connelly SM, Lewis LL, Murray J. Ribavirin Reduces Absolute Lymphocyte Counts in Hepatitis C Virus-Infected Patients Treated With Interferon-Free, Direct-Acting Antiviral Regimens. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 26021996 DOI: 10.1093/cid/civ419  0.353
2015 Harrington PR, Deming DJ, Komatsu TE, Naeger LK. Hepatitis C Virus RNA Levels During Interferon-Free Combination Direct-Acting Antiviral Treatment in Registrational Trials. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 61: 666-7. PMID 26002846 DOI: 10.1093/cid/civ402  0.659
2015 Donaldson EF, Harrington PR, O'Rear JJ, Naeger LK. Clinical evidence and bioinformatics characterization of potential hepatitis C virus resistance pathways for sofosbuvir. Hepatology (Baltimore, Md.). 61: 56-65. PMID 25123381 DOI: 10.1002/Hep.27375  0.62
2011 Kwong AD, Najera I, Bechtel J, Bowden S, Fitzgibbon J, Harrington P, Kempf D, Kieffer TL, Koletzki D, Kukolj G, Lim S, Pilot-Matias T, Lin K, Mani N, Mo H, et al. Sequence and phenotypic analysis for resistance monitoring in hepatitis C virus drug development: recommendations from the HCV DRAG. Gastroenterology. 140: 755-60. PMID 21255574 DOI: 10.1053/J.Gastro.2011.01.029  0.306
2009 Harrington PR, Schnell G, Letendre SL, Ritola K, Robertson K, Hall C, Burch CL, Jabara CB, Moore DT, Ellis RJ, Price RW, Swanstrom R. Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course. Aids (London, England). 23: 907-15. PMID 19414991 DOI: 10.1097/Qad.0B013E3283299129  0.309
2009 Schnell G, Spudich S, Harrington P, Price RW, Swanstrom R. Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia. Plos Pathogens. 5: e1000395. PMID 19390619 DOI: 10.1371/Journal.Ppat.1000395  0.376
2009 Ince WL, Harrington PR, Schnell GL, Patel-Chhabra M, Burch CL, Menezes P, Price RW, Eron JJ, Swanstrom RI. Major coexisting human immunodeficiency virus type 1 env gene subpopulations in the peripheral blood are produced by cells with similar turnover rates and show little evidence of genetic compartmentalization. Journal of Virology. 83: 4068-80. PMID 19211740 DOI: 10.1128/Jvi.02486-08  0.327
2007 Harrington PR, Connell MJ, Meeker RB, Johnson PR, Swanstrom R. Dynamics of simian immunodeficiency virus populations in blood and cerebrospinal fluid over the full course of infection. The Journal of Infectious Diseases. 196: 1058-67. PMID 17763329 DOI: 10.1086/520819  0.367
2007 Van Rie A, Harrington PR, Dow A, Robertson K. Neurologic and neurodevelopmental manifestations of pediatric HIV/AIDS: a global perspective. European Journal of Paediatric Neurology : Ejpn : Official Journal of the European Paediatric Neurology Society. 11: 1-9. PMID 17137813 DOI: 10.1016/J.Ejpn.2006.10.006  0.303
2006 LoBue AD, Lindesmith L, Yount B, Harrington PR, Thompson JM, Johnston RE, Moe CL, Baric RS. Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains. Vaccine. 24: 5220-34. PMID 16650512 DOI: 10.1016/J.Vaccine.2006.03.080  0.613
2005 Harrington PR, Haas DW, Ritola K, Swanstrom R. Compartmentalized human immunodeficiency virus type 1 present in cerebrospinal fluid is produced by short-lived cells. Journal of Virology. 79: 7959-66. PMID 15956542 DOI: 10.1128/Jvi.79.13.7959-7966.2005  0.35
2004 Harrington PR, Vinjé J, Moe CL, Baric RS. Norovirus capture with histo-blood group antigens reveals novel virus-ligand interactions. Journal of Virology. 78: 3035-45. PMID 14990722 DOI: 10.1128/Jvi.78.6.3035-3045.2004  0.533
2002 Harrington PR, Lindesmith L, Yount B, Moe CL, Baric RS. Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice. Journal of Virology. 76: 12335-43. PMID 12414974 DOI: 10.1128/Jvi.76.23.12335-12343.2002  0.55
2002 Baric RS, Yount B, Lindesmith L, Harrington PR, Greene SR, Tseng FC, Davis N, Johnston RE, Klapper DG, Moe CL. Expression and self-assembly of norwalk virus capsid protein from venezuelan equine encephalitis virus replicons. Journal of Virology. 76: 3023-30. PMID 11861868 DOI: 10.1128/Jvi.76.6.3023-3030.2002  0.498
2002 Harrington PR, Yount B, Johnston RE, Davis N, Moe C, Baric RS. Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles. Journal of Virology. 76: 730-42. PMID 11752163 DOI: 10.1128/Jvi.76.2.730-742.2002  0.571
Show low-probability matches.